Whereas the cancer genomes mutations identified to have a strong A3A-like character by the criteria outlined by ref. 39 do clearly display the intrinsic secondary structure preferences of the A3A enzyme, the same is not true of mutations in tumors with supposedly strong A3B-like character (Fig. 5A, B, C). The gene discussed is APOBEC3A; the disease is cancer.